Saiju Jacob

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†

Maria Isabel Leite, Saiju Jacob, Stuart Viegas et al. · Brain · 2008 · 508 citations · Full text

Aquaporin-4 Antibodies in Neuromyelitis Optica and Longitudinally Extensive Transverse Myelitis

Patrick Waters, Sven Jarius, Edward Littleton et al. · Archives of Neurology · 2008 · 291 citations

Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis

Srikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar et al. · Muscle & Nerve · 2019 · 239 citations · Full text

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

Saiju Jacob, Srikanth Muppidi, Amanda C. Guidon et al. · Journal of the Neurological Sciences · 2020 · 154 citations · Full text